Telix Pharmaceuticals Limited

TLPPF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$0$5-$104-$81
Dep. & Amort.$0$7$5$5
Deferred Tax$0$0-$13-$14
Stock-Based Comp.$0$9$8$1
Change in WC-$64-$58-$1-$3
Other Non-Cash$107$60$41$32
Operating Cash Flow$43$24-$64-$59
Investing Activities
PP&E Inv.-$14-$10-$14-$1
Net Acquisitions-$35-$1-$1$0
Inv. Purchases-$52-$13$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$34-$1-$2-$1
Investing Cash Flow-$135-$25-$17-$3
Financing Activities
Debt Repay.$653$6$3-$0
Stock Issued$1$7$123$4
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$15-$2-$1-$1
Financing Cash Flow$639$10$175$3
Forex Effect$40-$2$0$3
Net Chg. in Cash$587$7$94-$56
Supplemental Information
Beg. Cash$123$116$22$78
End Cash$710$123$116$22
Free Cash Flow$9$13-$78-$61